Novel 18F-labeled PET Imaging Agent FV45 targeting the Renin-Angiotensin System
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: ACS Omega, 2018, 3 (9), pp 10460–10470. DOI: 10.1021/acsomega.8b01885
- Schlagwort
-
Positronen-Emissions-Tomografie
- Ereignis
-
Veröffentlichung
- (wo)
-
Würzburg
- (wer)
-
Universität Würzburg
- (wann)
-
2018
- Urheber
- URN
-
urn:nbn:de:bvb:20-opus-167144
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.3030, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Chen, Xinyu
- Hirano, Mitsuru
- Wolf, Herta
- Decker, Michael
- Higuchi, Takahiro
- Universität Würzburg
Entstanden
- 2018
Ähnliche Objekte (12)
Synthesis and Initial Characterization of a Selective, Pseudo‐irreversible Inhibitor of Human Butyrylcholinesterase as PET Tracer
Synthesis and Initial Characterization of a Reversible, Selective 18F-Labeled Radiotracer for Human Butyrylcholinesterase
Synthesis and Initial Characterization of a Selective, Pseudo‐irreversible Inhibitor of Human Butyrylcholinesterase as PET Tracer
Synthesis and initial characterization of a reversible, selective 18F-labeled radiotracer for human butyrylcholinesterase
Radionuclide imaging of neurohormonal system of the heart
Synthesis and initial characterization of a selective, pseudo‐irreversible inhibitor of human butyrylcholinesterase as PET tracer
Navigating new horizons: prospects of NET-targeted radiopharmaceuticals in precision medicine
Design, synthesis and pharmacological studies of novel multivalent and -funtional anti-Alzheimer's disease agents
Moving into the Next Era of PET Myocardial Perfusion Imaging - Introduction of Novel 18F-labeled Tracers
Moving into the next era of PET myocardial perfusion imaging: introduction of novel 18F-labeled tracers
Small Molecule Intervention for Inflammation: Utilising GPCR Ligands and Butyrylcholinesterase Inhibitors in Diagnosis and Therapy
Einfluss von Stossprozessen auf die zweidimensionale Temperaturfeldbestimmung mittels laserinduzierter Fluoreszenz an molekularem Sauerstoff unter Hochdruckbedingungen
Synthesis and Initial Characterization of a Selective, Pseudo‐irreversible Inhibitor of Human Butyrylcholinesterase as PET Tracer
Synthesis and Initial Characterization of a Reversible, Selective 18F-Labeled Radiotracer for Human Butyrylcholinesterase
Synthesis and Initial Characterization of a Selective, Pseudo‐irreversible Inhibitor of Human Butyrylcholinesterase as PET Tracer
Synthesis and initial characterization of a reversible, selective 18F-labeled radiotracer for human butyrylcholinesterase
Radionuclide imaging of neurohormonal system of the heart
Synthesis and initial characterization of a selective, pseudo‐irreversible inhibitor of human butyrylcholinesterase as PET tracer
Navigating new horizons: prospects of NET-targeted radiopharmaceuticals in precision medicine
Design, synthesis and pharmacological studies of novel multivalent and -funtional anti-Alzheimer's disease agents
Moving into the Next Era of PET Myocardial Perfusion Imaging - Introduction of Novel 18F-labeled Tracers
Moving into the next era of PET myocardial perfusion imaging: introduction of novel 18F-labeled tracers
Small Molecule Intervention for Inflammation: Utilising GPCR Ligands and Butyrylcholinesterase Inhibitors in Diagnosis and Therapy
Einfluss von Stossprozessen auf die zweidimensionale Temperaturfeldbestimmung mittels laserinduzierter Fluoreszenz an molekularem Sauerstoff unter Hochdruckbedingungen
Synthesis and Initial Characterization of a Selective, Pseudo‐irreversible Inhibitor of Human Butyrylcholinesterase as PET Tracer
Synthesis and Initial Characterization of a Reversible, Selective 18F-Labeled Radiotracer for Human Butyrylcholinesterase
Synthesis and Initial Characterization of a Selective, Pseudo‐irreversible Inhibitor of Human Butyrylcholinesterase as PET Tracer
Synthesis and initial characterization of a reversible, selective 18F-labeled radiotracer for human butyrylcholinesterase
Radionuclide imaging of neurohormonal system of the heart
Synthesis and initial characterization of a selective, pseudo‐irreversible inhibitor of human butyrylcholinesterase as PET tracer
Navigating new horizons: prospects of NET-targeted radiopharmaceuticals in precision medicine
Design, synthesis and pharmacological studies of novel multivalent and -funtional anti-Alzheimer's disease agents
Moving into the Next Era of PET Myocardial Perfusion Imaging - Introduction of Novel 18F-labeled Tracers
Moving into the next era of PET myocardial perfusion imaging: introduction of novel 18F-labeled tracers
Small Molecule Intervention for Inflammation: Utilising GPCR Ligands and Butyrylcholinesterase Inhibitors in Diagnosis and Therapy